# OnCo record polcagb (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/polcagb/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "polcagb", "NCT02867865" ;
  schema:name "POLCAGB"@en ;
  schema:description "In Mumbai, where gallbladder cancer is common, POLCAGB randomised patients with locally advanced but non-metastatic gallbladder cancer to chemotherapy or chemoradiotherapy before surgery. It is the largest randomised trial in gallbladder cancer alone and finished recruiting 124 patients in 2025."@en ;
  schema:url <https://onco.cc/trials/polcagb/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02867865>, <https://doi.org/10.1136/bmjopen-2018-028147>, <https://doi.org/10.4103/ijc.ijc_822_19> ;
  onco:status "active" ;
  onco:phase "2/3" ;
  onco:cancers <https://onco.cc/cancers/gallbladder/>, <https://onco.cc/cancers/incidental-gallbladder-cancer/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/>, <https://onco.cc/technologies/gallbladder-cancer-surgery/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine-cisplatin/>, <https://onco.cc/drugs/gemcitabine/>, <https://onco.cc/drugs/cisplatin/> ;
  onco:institutions <https://onco.cc/institutions/tata-memorial/> ;
  onco:terms <https://onco.cc/terms/chemoradiation/>, <https://onco.cc/terms/staging-laparoscopy/>, <https://onco.cc/terms/neoadjuvant-adjuvant/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-polcagb-protocol-bmj-open-2019/> .
